Found 0 matching trials
Pharmacokinetic Study in Healthy Males PHASE1 The purpose of this study is to investigate the pharmacokinetics of levodop...
Show More Learn More & Join Trial
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off PHASE4 The purpose of this study is to test the effects of carbidopa/levodopa/enta...
Show More Learn More & Join Trial
A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease PHASE2 It is a phase II randomized, parallel, double-blind, placebo-controlled, mu...
Show More Location
Shanghai Huashan Hospital
Learn More & Join Trial
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease NA This study investigates whether there is a change in 123iodine-2ß- carbomet...
Show More Location
Department of Neurology, Innsbruck Medical University
Learn More & Join Trial
Cognitive Remediation for Cocaine Dependence PHASE2 The purpose of this study is to evaluate treatments designed to improve coc...
Show More Location
Behavioral and Biomedical Sciences Building
Learn More & Join Trial
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease PHASE3 The primary objective of this study will be to provide further evidence of ...
Show More Location
Site Reference ID/Investigator# 50065
Learn More & Join Trial
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease PHASE2 This is a multi-center, international, open-label, safety study of ND0612, ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa) PHASE1 A Single Period Investigation to Assess the Tolerability of Healthy Subject...
Show More Location
Multiple Locations
Learn More & Join Trial
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm PHASE1 Walking with age becomes both slower and less 'automated', requiring more a...
Show More Location
Domino's Farms
Learn More & Join Trial
Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease PHASE3 Parkinson's disease (PD) is a neurological condition, which affects the bra...
Show More Location
University of Alabama at Birmingham - Main /ID# 215597
Learn More & Join Trial